Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
SGCE encodes the epsilon member of the sarcoglycan family. Additionally we are shipping SGCE Proteins (7) and many more products for this protein.
Showing 10 out of 29 products:
Cow (Bovine) Polyclonal SGCE Primary Antibody for IHC, WB - ABIN2782610
Hjermind, Vissing, Asmus, Krag, Lochmüller, Walter, Erdal, Blake, Nielsen: No muscle involvement in myoclonus-dystonia caused by epsilon-sarcoglycan gene mutations. in European journal of neurology : the official journal of the European Federation of Neurological Societies 2008
SGCE mutation can cause a broad range of clinical symptoms between and within families. We should consider MDS (show PAFAH1B1 Antibodies) as a differential diagnosis for patients with paroxysmal walking abnormalities and/or myoclonic movements.
Tata confirms that SGCE mutations are most commonly identified in Myoclonus dystonia syndrome patients with (1) age at onset =10 years and (2) predominant upper body involvement of a pure myoclonus-dystonia.
found one patient with a novel heterozygous frameshift mutation in the DYT11 gene
The co-occurrence of seizures and myoclonus-dystonia suggests that they are both due to the same underlying SGCE mutation
A novel frameshift mutation of the SGCE gene in an Iranian family with Myoclonus-dystonia syndrome confirming the variability of the clinical symptoms caused by the same mutation within members of a family.
In myoclonus-dystonia syndrome patients a substantial mutation in exon 3 of SGCE gene was found.
The results of this study suggested performing gene dosage analysis by multiple ligation-dependent probe amplification (MLPA) to individuate large SGCE deletions that can be responsible for complex phenotypes.
SGCE mutations are associated with a specific psychiatric phenotype consisting of compulsivity, anxiety and alcoholism in addition to the characteristic motor phenotype.
Although reduced penetrance in DYT11-MD has been attributed to the maternal imprinting epsilon-sarcoglycan mutations, NM-DYT11 carriers showed significant metabolic abnormalities that are not explained by this genetic model.
anxiety disorders and executive dysfunctions may be part of the phenotype of myoclonus-dystonia patients with a DYT11 mutation
The results suggest that varepsilon-sarcoglycan (show SGCD Antibodies) in the cerebellar Purkinje cells contributes to the motor learning, while loss of varepsilon-sarcoglycan (show SGCD Antibodies) in other brain regions may contribute to nuclear envelope abnormality, myoclonus and motor coordination deficits.
results suggest that the loss of epsilon-sarcoglycan in the striatum contributes to motor deficits, while it alone does not produce abnormal nuclear envelopes or myoclonus
impaired ectodomain shedding of M68T, a process that occurs physiologically for epsilon-sarcoglycan resulting in the lysosomal trafficking of the intracellular C-terminal domain of the protein. ( epsilon-sarcoglycan )
Sgca (show SGCA Antibodies)-;Sgce-null mouse shows a complete loss of residual sarcoglycans and a strong reduction in both dystrophin (show DMD Antibodies) and dystroglycan (show DAG1 Antibodies).
Data describe mice carrying mutations in both Dyt1 (show TOR1A Antibodies) and Sgce and show that these double mutant mice show earlier onset of motor deficits in beam-walking test.
Sgce gene is imprinted, with exclusive expression from the paternal allele.
These results suggest that the two epsilon-SG isoforms might play different roles in synaptic functions of the central nervous system.
High expression levels of epsilon-sarcoglycan mRNA and protein were found in the mitral cell layer of the olfactory bulb, the Purkinje cell layer in cerebellum, and the monoaminergic neurons in the mouse midbrain.
diverse symptoms associated with myoclonus-dystonia are indeed resulted from a single SGCE gene mutation that leads to alterations of dopaminergic and serotonergic systems.
Data demonstrate a novel function of the sarcoglycan (show SGCD Antibodies) complex in whole body glucose homeostasis and skeletal muscle metabolism, suggesting that the impairment of the skeletal muscle metabolism influences the pathogenesis of muscular dystrophy.
This gene encodes the epsilon member of the sarcoglycan family. Sarcoglycans are transmembrane proteins that are components of the dystrophin-glycoprotein complex, which link the actin cytoskeleton to the extracellular matrix. Unlike other family members which are predominantly expressed in striated muscle, the epsilon sarcoglycan is more broadly expressed. Mutations in this gene are associated with myoclonus-dystonia syndrome. This gene is imprinted, with preferential expression from the paternal allele. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
, dystonia 11, myoclonic